Speaker Profile
Ph.D., MSC, Associate Member/Professor, Fred Hutchinson Cancer Research Center/University of Washington
Biography
Dr. Lotte Steuten is an entrepreneurial academic, striving to accelerate patient access to high-value healthcare innovations. She has global expertise in health economics that she applies to identifying, building and articulating the clinical, humanistic and economic value of precision medicine. As an Associate Member at Fred Hutch and Affiliate Associate Professor at UW, Lotte conducts an active research program in comparative effectiveness research and health policy. She is an advisor to various research organizations, policy boards and healthcare industries, and is co-founder and Chief Scientific Officer of Panaxea – a medtech consulting firm. Lotte accrued her global expertise as at leading health economic groups in the US, UK and the Netherlands. She obtained an MSc in Health Sciences and a PhD (cum laude) in Health Economics from Maastricht University, the Netherlands.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision Medicine’s value is undeniable. But what about its financial impact? And how should we assess its value beyond the field of oncology? This session will cover the unsustainable economics at play, reimbursement challenges and policies, and cost-based pricing versus value-based pricing, from a patient, pharma, payor, and molecular diagnostics perspective.
